1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bio-imaging Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Bio-imaging by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Bio-imaging by Country/Region, 2020, 2024 & 2031
2.2 Bio-imaging Segment by Type
2.2.1 X-ray Radiography
2.2.2 Medical Ultrasonography or Ultrasound
2.2.3 Magnetic Resonance Imaging
2.2.4 Elastography
2.2.5 Other
2.3 Bio-imaging Sales by Type
2.3.1 Global Bio-imaging Sales Market Share by Type (2020-2025)
2.3.2 Global Bio-imaging Revenue and Market Share by Type (2020-2025)
2.3.3 Global Bio-imaging Sale Price by Type (2020-2025)
2.4 Bio-imaging Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Bio-imaging Sales by Application
2.5.1 Global Bio-imaging Sale Market Share by Application (2020-2025)
2.5.2 Global Bio-imaging Revenue and Market Share by Application (2020-2025)
2.5.3 Global Bio-imaging Sale Price by Application (2020-2025)
3 Global Bio-imaging by Company
3.1 Global Bio-imaging Breakdown Data by Company
3.1.1 Global Bio-imaging Annual Sales by Company (2020-2025)
3.1.2 Global Bio-imaging Sales Market Share by Company (2020-2025)
3.2 Global Bio-imaging Annual Revenue by Company (2020-2025)
3.2.1 Global Bio-imaging Revenue by Company (2020-2025)
3.2.2 Global Bio-imaging Revenue Market Share by Company (2020-2025)
3.3 Global Bio-imaging Sale Price by Company
3.4 Key Manufacturers Bio-imaging Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bio-imaging Product Location Distribution
3.4.2 Players Bio-imaging Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2025)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bio-imaging by Geographic Region
4.1 World Historic Bio-imaging Market Size by Geographic Region (2020-2025)
4.1.1 Global Bio-imaging Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Bio-imaging Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bio-imaging Market Size by Country/Region (2020-2025)
4.2.1 Global Bio-imaging Annual Sales by Country/Region (2020-2025)
4.2.2 Global Bio-imaging Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bio-imaging Sales Growth
4.4 APAC Bio-imaging Sales Growth
4.5 Europe Bio-imaging Sales Growth
4.6 Middle East & Africa Bio-imaging Sales Growth
5 Americas
5.1 Americas Bio-imaging Sales by Country
5.1.1 Americas Bio-imaging Sales by Country (2020-2025)
5.1.2 Americas Bio-imaging Revenue by Country (2020-2025)
5.2 Americas Bio-imaging Sales by Type
5.3 Americas Bio-imaging Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bio-imaging Sales by Region
6.1.1 APAC Bio-imaging Sales by Region (2020-2025)
6.1.2 APAC Bio-imaging Revenue by Region (2020-2025)
6.2 APAC Bio-imaging Sales by Type
6.3 APAC Bio-imaging Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bio-imaging by Country
7.1.1 Europe Bio-imaging Sales by Country (2020-2025)
7.1.2 Europe Bio-imaging Revenue by Country (2020-2025)
7.2 Europe Bio-imaging Sales by Type
7.3 Europe Bio-imaging Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bio-imaging by Country
8.1.1 Middle East & Africa Bio-imaging Sales by Country (2020-2025)
8.1.2 Middle East & Africa Bio-imaging Revenue by Country (2020-2025)
8.2 Middle East & Africa Bio-imaging Sales by Type
8.3 Middle East & Africa Bio-imaging Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bio-imaging
10.3 Manufacturing Process Analysis of Bio-imaging
10.4 Industry Chain Structure of Bio-imaging
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bio-imaging Distributors
11.3 Bio-imaging Customer
12 World Forecast Review for Bio-imaging by Geographic Region
12.1 Global Bio-imaging Market Size Forecast by Region
12.1.1 Global Bio-imaging Forecast by Region (2026-2031)
12.1.2 Global Bio-imaging Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bio-imaging Forecast by Type
12.7 Global Bio-imaging Forecast by Application
13 Key Players Analysis
13.1 BioClinica
13.1.1 BioClinica Company Information
13.1.2 BioClinica Bio-imaging Product Portfolios and Specifications
13.1.3 BioClinica Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BioClinica Main Business Overview
13.1.5 BioClinica Latest Developments
13.2 Bracco Imaging
13.2.1 Bracco Imaging Company Information
13.2.2 Bracco Imaging Bio-imaging Product Portfolios and Specifications
13.2.3 Bracco Imaging Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bracco Imaging Main Business Overview
13.2.5 Bracco Imaging Latest Developments
13.3 FONAR Corporation
13.3.1 FONAR Corporation Company Information
13.3.2 FONAR Corporation Bio-imaging Product Portfolios and Specifications
13.3.3 FONAR Corporation Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 FONAR Corporation Main Business Overview
13.3.5 FONAR Corporation Latest Developments
13.4 Bayer HealthCare
13.4.1 Bayer HealthCare Company Information
13.4.2 Bayer HealthCare Bio-imaging Product Portfolios and Specifications
13.4.3 Bayer HealthCare Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Bayer HealthCare Main Business Overview
13.4.5 Bayer HealthCare Latest Developments
13.5 Medtronic
13.5.1 Medtronic Company Information
13.5.2 Medtronic Bio-imaging Product Portfolios and Specifications
13.5.3 Medtronic Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Medtronic Main Business Overview
13.5.5 Medtronic Latest Developments
13.6 Digirad Corporation
13.6.1 Digirad Corporation Company Information
13.6.2 Digirad Corporation Bio-imaging Product Portfolios and Specifications
13.6.3 Digirad Corporation Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Digirad Corporation Main Business Overview
13.6.5 Digirad Corporation Latest Developments
13.7 Esaote
13.7.1 Esaote Company Information
13.7.2 Esaote Bio-imaging Product Portfolios and Specifications
13.7.3 Esaote Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Esaote Main Business Overview
13.7.5 Esaote Latest Developments
13.8 Hitachi Medical
13.8.1 Hitachi Medical Company Information
13.8.2 Hitachi Medical Bio-imaging Product Portfolios and Specifications
13.8.3 Hitachi Medical Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Hitachi Medical Main Business Overview
13.8.5 Hitachi Medical Latest Developments
13.9 Gamma Medica
13.9.1 Gamma Medica Company Information
13.9.2 Gamma Medica Bio-imaging Product Portfolios and Specifications
13.9.3 Gamma Medica Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Gamma Medica Main Business Overview
13.9.5 Gamma Medica Latest Developments
13.10 GE Healthcare
13.10.1 GE Healthcare Company Information
13.10.2 GE Healthcare Bio-imaging Product Portfolios and Specifications
13.10.3 GE Healthcare Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 GE Healthcare Main Business Overview
13.10.5 GE Healthcare Latest Developments
13.11 Positron Corporation
13.11.1 Positron Corporation Company Information
13.11.2 Positron Corporation Bio-imaging Product Portfolios and Specifications
13.11.3 Positron Corporation Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Positron Corporation Main Business Overview
13.11.5 Positron Corporation Latest Developments
13.12 Philips Healthcare
13.12.1 Philips Healthcare Company Information
13.12.2 Philips Healthcare Bio-imaging Product Portfolios and Specifications
13.12.3 Philips Healthcare Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Philips Healthcare Main Business Overview
13.12.5 Philips Healthcare Latest Developments
13.13 SonoSite
13.13.1 SonoSite Company Information
13.13.2 SonoSite Bio-imaging Product Portfolios and Specifications
13.13.3 SonoSite Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 SonoSite Main Business Overview
13.13.5 SonoSite Latest Developments
13.14 Siemens Healthcare
13.14.1 Siemens Healthcare Company Information
13.14.2 Siemens Healthcare Bio-imaging Product Portfolios and Specifications
13.14.3 Siemens Healthcare Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Siemens Healthcare Main Business Overview
13.14.5 Siemens Healthcare Latest Developments
13.15 Shimadzu
13.15.1 Shimadzu Company Information
13.15.2 Shimadzu Bio-imaging Product Portfolios and Specifications
13.15.3 Shimadzu Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Shimadzu Main Business Overview
13.15.5 Shimadzu Latest Developments
13.16 Canon Medical Systems
13.16.1 Canon Medical Systems Company Information
13.16.2 Canon Medical Systems Bio-imaging Product Portfolios and Specifications
13.16.3 Canon Medical Systems Bio-imaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Canon Medical Systems Main Business Overview
13.16.5 Canon Medical Systems Latest Developments
14 Research Findings and Conclusion
※参考情報 バイオイメージングは、生物学的プロセスを視覚的に表現する手法を指し、主に生体内の構造や機能を可視化するために用いられます。この技術は、健康診断や研究分野での診断手法として幅広く活用されており、科学的理解を深めるだけでなく、新たな治療法の発見にも寄与しています。 バイオイメージングの定義は、生物の内部構造や機能、さらには細胞や分子レベルの動態をリアルタイムで観察する技術といえます。この技術により、従来の観察方法では困難であった詳細な情報が得られるようになり、特に病気の早期発見や新薬の開発において重要な役割を果たしています。 バイオイメージングの特徴としては、非侵襲性、タイムリース、選択性の高い観察が挙げられます。非侵襲性とは、対象組織を傷つけることなく観察できることを意味し、これは患者に対しても優しいアプローチとされています。また、リアルタイムでの観察が可能であるため、細胞や組織の動きを直接確認することができます。さらに、特定の分子や細胞に対して高い選択性を持つプローブを使用することで、特定のターゲットを識別しやすくする点も大きな特徴です。 バイオイメージングの種類は多岐にわたりますが、代表的な技術としては、以下のものが挙げられます。 1. **CT(コンピュータ断層撮影)**: X線を用いて体内の断面画像を得る技術で、骨や腫瘍の検出に優れています。 2. **MRI(磁気共鳴画像法)**: 磁場と電波を利用して体内の水分分布を画像化します。脳や筋肉、軟部組織の詳細な画像を提供するため、神経科学や整形外科などで広く使用されています。 3. **PET(陽電子放射断層撮影)**: 放射性同位元素を用いた手法で、代謝活性を持つ細胞や組織を観察するのに適しています。がんの診断や心筋の評価に頻繁に使用されます。 4. **超音波(エコー)**: 音波を使用して体内の構造を視覚化する方法で、非侵襲かつリアルタイムでの観察が可能です。妊娠中の胎児観察などに一般的に使用されています。 5. **フルオレセンスイメージング**: 蛍光物質を用いて特定の細胞や分子を染色し、光を照射することによってその存在を可視化します。研究室での細胞評価や、がん細胞の特定などに利用されています。 バイオイメージングの用途は非常に広範で、医療分野では診断、治療、モニタリングに利用されています。例えば、がんの早期発見や、治療法の効果を確認するための評価に役立ちます。また、神経科学の領域では、脳の活動をリアルタイムで観察することで、疾患のメカニズムを解明するための研究が進められています。 さらに、バイオイメージングは進化した技術として、オミックス解析やバイオマーカーの評価とも密接に関連しています。例えば、特定のプローブを用いたイメージング技術は、個々の患者に適した治療法の選択に貢献できる可能性があります。これにより、個別化医療の進展も期待されています。 関連技術としては、例えば、ラマン分光法や質量分析法がバイオイメージングに組み合わされることがあります。これらの技術は、細胞や組織内の分子の特定やその相互作用の解明に寄与するため、バイオイメージングの精度をさらに向上させる要因となります。最近では、AI技術がイメージングデータの解析にも導入されており、大量のデータから有益な情報を引き出すための手法として注目を集めています。 バイオイメージング技術の発展は今後も続き、新しいイメージングプローブや技術の開発が進むことで、さらに詳細な解析や適応が可能となります。将来的には、病気の予防、早期診断、個別化された治療法の構築に寄与することが期待されています。このように、バイオイメージングは生物医学において重要な役割を果たし、医療と研究の双方において革新をもたらす技術となるでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/